Our previous work on triple-negative breast cancer (TNBC) revealed the involvement of CD24 in TNBC progression and metastatic lung colonization via enhancing anoikis resistance and angiogenesis through receptor tyrosine kinase (RTK) oncogenic pathways such as EGFR and MET [13]. The gene discussed is CD24; the disease is triple-negative breast carcinoma.